Staging ::: VER CORREOS
Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
7.504 / 17.039
#60025

Re: Farmas USA

A cuanto va LLBo?

#60026

Re: Farmas USA

47, pero no podemos pasarnos la tarde cantando el precio....jajajaja

Ha llegado a 52....

#60027

Re: Farmas USA

HZNP

No sé si aún la sigue alguien:

No later than March 19, Horizon Pharma (NASDAQ:HZNP) will issue 6,011,543 shares of common stock to convert an aggregate of $32.2M of its 5% Convertible Senior Notes due 2018. In addition, it will make an aggregate cash payment of $5.9M to the note holders for exchange consideration and accrued and unpaid interest.
After the transaction, $28.7M of Convertible Notes will remain outstanding.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#60028

Re: Farmas USA

INO

Resultado por debajo de expectativas dicen, pero sube :)

Inovio Pharmaceuticals (NASDAQ:INO): Q4 EPS of -$0.12 misses by $0.02.
Revenue of $2.5M (+43.7% Y/Y) misses by $2.74M.

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#60030

Re: Farmas USA

GALE

Aquí van los datos del offering. Me parece una oportunidad de entrada cojonuda a los niveles de hoy.

public offering by us of 24,358,974 shares of our common stock, par value $0.0001 per share, and warrants to purchase up to 12,179,487 of shares of our common stock at an exercise price of $2.08 per whole share of common stock. The shares of common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.5 of a share of common stock. Each unit will be sold at a price of $1.56 per unit. The shares of common stock and warrants will be mandatorily separable immediately upon issuance.

The Underwriters will purchase the units from us at a price of $1.4664 per unit, representing a 6% discount from the public offering price. Pursuant to the Underwriting Agreement, we have granted the Underwriters an option for a period of 30 days from the date of the final prospectus supplement to purchase from us up to an additional 3,653,846 shares of common stock at a price of $1.457 per share and/or additional warrants to purchase up to 1,826,923 shares of common stock at a price of $0.0094 per warrant to cover over-allotments, if any.

http://investors.galenabiopharma.com/secfiling.cfm?filingid=1193125-15-91718&CIK=1390478

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#60031

Re: Farmas USA

Yo he intentado hacerle alguna entrada y no he acertado....
De todos modos, la tengo en watchlist para irla siguiendo....

GALE

#60032

Re: Farmas USA

Me salgo de NBS.....
Otra que saca buenos resultados de Fase II, y tras abrir en verde, se hunde, como hizo CUR...
Y además, sin artículo de AF...
A esperarla más abajo

NBS